1. Warren J. R., Marshall B. J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273-5. PMID: 6134060.
2. Bizzozero G. Uber die schlauchformigen Drusen den Magen-Darms Kanals und die Besichungen ehres Epithelis zu dem oberflachenepitel der Scheimhcuit. Arch. Mikr. Anat. 1893; Bd.42: 83-96.
3. Salomon H. Uber das spirilliam des Sangetiermagens und sein verhalten zu den Belegzellen. Zbl. Bact. 1896; Bd.19: 433-442.
4. Malfertheiner P., Megraud F., O’Morain C. A., et al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017, Jan; 66 (1): 6-30. https://doi.org/10.1136/gutjnl-2016-312288.
5. Jones N. L., Koletzko S., Goodman K., et al.; ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017; 64 (6): 99; 1-1003. https://doi.org/10.1097/MPG.0000000000001594.
6. Ivashkin V.T., Mayev I. V., Lapina T. L., et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55-70. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-1-55-70.
7. Union of Pediatricians of Russia. Clinical guidelines Gastric ulcer and / or duodenal ulcer in children. Moscow. 2016. ID: KR388. Available at: http://cr.rosminzdrav.ru/index.html#!/schema/246#doc_v Russian Access: 05.05.19.
8. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007. 56(5):631-636. https://doi.org/10.1136/gut.2006.106666.
9. Tringali A, Thomson M, Dumonceau JM, et al. Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Guideline Executive summary. Endoscopy. 2017; 49: 83-91. https://doi.org/10.1055/s-0042-111002.
10. Hyams J.S., Di Lorenzo C., Saps M. Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology. 2016. 150:1456-1468. https://doi.org/10.1053/j.gastro.2016.02.015.
11. Schreiber-Dietrich D., Hocke M., Braden B., Carrara S., Gottschalk U., Dietrich C. F. Pediatric Endoscopy, Update 2020. Applied Sciences. 2019; 9(23):5036. https://doi.org/10.3390/app9235036.
12. Roma E., Miele E. Helicobacter pylori Infection in Pediatrics. Helicobacter. 2015 Sep;20 Suppl 1:47-53. https://doi.org/10.1111/hel.12257.
13. Kornienko E. A. Helicobacter pylori infection in children. Moscow. GEOTAR-media Publ., 2011, 272 p. (in Russ.)
14. Makristathis A., Hirschi A. M., Megraud F., Bessede E. Review: Diagnosis of Helicobacter pylori infection. Helicobacter. 2019; 24(S1): e12641. https://doi.org/10.1111/hel.12641.
15. Nijevitch A.A., Sataev V. U., Akhmadeyeva E. N., et al. Nifuratel-containing initial anti Helicobacter pylori triple therapy in children. Helicobacter. 2007 Apr;12(2):132-5. https://doi.org/10.1111/j.1523-5378.2007.00482.x.
16. Dekhnich N.N., Tryapyshko A. A., Trushin I. V., Kuzmenkov A. Yu., Kozlov R. S. Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients. Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):119-127. (in Russ.) https://doi.org/10.36488/cmac.2020.2.119-127.
17. Uspensky Yu.P., Baryshnikova N. V. Use of nitrofuran derivatives in first-line eradication therapy regimens. RMZh, 2012; (35): 1694. (in Russ.)
18. Graham D.Y., Lu H. Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread. Saudi J Gastroenterol. 2012; 18:1-2. https://doi.org/10.4103/1319-3767.91724
19. Mohammadi M., Attaran B., Malekzadeh R., et al. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Dig Dis Sci. 2017;62(8):1890-6. https://doi.org/10.1007/s10620-017-4628-5.
20. Liu W.Z., Xiao S. D., Hu P. J., et al. A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine. Aliment Pharmacol Ther. 2000 Nov;14(11):1519-22. https://doi.org/10.1046/j.1365-2036.2000.00845.x.
21. Lazebnik LB, Bordin DS; Research Group “Parad”. [Management of patients with Helicobacter pylori-related illness in the ordinary clinical practice. Intermediate results of monitoring program]. Eksp Klin Gastroenterol. 2013;(5):93-101. Russian. PMID: 24501953.
22. Dekhnich N.N., Ivanchik N. V., Kozlov R. S. Comparison of in vitro activity of various macrolides against Helicobacter pylori. Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):192-197. (In Russ.) https://doi.org/10.36488//cmac.2018.3.192-197.
23. Guslandi M. Review article: alternative antibacterial agents for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2001 Oct;15(10):1543-7. https://doi.org/10.1046/j.1365-2036.2001.01064.x. PMID: 11563992.
24. Iwańczak B.M., Borys-Iwanicka A., Biernat M., Gościniak G. Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics. Adv Clin Exp Med. 2016 Jul-Aug;25(4):701-8. https://doi.org/10.17219/acem/38554. PMID: 27629844.
25. Ahmadeeva E.N., Nijevich A. A., Kuchina E. S., Sataev V. U., Arzamastsev A. G. [Sequential anti-Helicobacter pylori therapy in children with chronic gastritis: a pilot study]. Pediatria. 2013; 92 (6): 85-87. (In Russ.)
26. Shi X., Zhang J., Mo L., Shi J, Qin M, Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis. Medicine (Baltimore). 2019; v.98(15): e15180. https://doi.org/10.1097/MD.0000000000015180.
27. Zhu R., Chen K., Zheng Y.-Y., et al. Meta-analysis of the effiacy of probiotics in Helicobacter pylori eradication therapy. World J Gastroenterol. 2014; 20 (47): 18013-18021. https://doi.org/10.3748/wjg.v20.i47.18013.
28. McFarland L. V., Huang Y., Wang L, Malfertheiner P. Systematic review and metaanalysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016; 4 (4): 546-561. https://doi.org/10.1177/2050640615617358.
29. Feng J. R., Wang F., Qiu X., McFarland L. V., Chen P. F., Zhou R., Liu J., Zhao Q., Li J. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. Eur J Clin Pharmacol. 2017, Oct; 73 (10): 1199-1208. https://doi.org/10.1007/s00228-017-2291-6.
30. Kornienko E.A., Parolova N. I. Gastric microbiota and potentials of probiotics in the eradication of H. pylori. Farmateka. 2017; 13: 22-29. (in Russ.)
S. V. Belmer,
E. A. Kornienko, 
Email this article 